Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Adjuvant treatment luminal in breast cancer

Endocrine therapy beyond 5 years: Who to treat and for what duration

Date

05 May 2022

Session

Adjuvant treatment luminal in breast cancer

Topics

Cytotoxic Therapy

Tumour Site

Breast Cancer

Presenters

Lucia Del Mastro

Authors

L. Del Mastro

Author affiliations

  • IRCCS Ospedale Policlinico San Martino Hospital – University of Genova, Genova/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.